www.fdanews.com/articles/129930-prometheus-launches-test-to-predict-risk-of-complications-from-crohn-rsquo-s

Prometheus Launches Test to Predict Risk of Complications From Crohn’s

August 31, 2010

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, Tuesday announced the commercial launch of its proprietary PROMETHEUS Crohn’s Prognostic test.
TheStreet